Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
LENZ Therapeutics (LENZ) has issued an announcement.
LENZ Therapeutics, Inc. has struck a deal with Ridgeback Capital Investment, L.P. for a private sale of over 1.5 million shares at $19 each, aiming to raise around $30 million. The shares, which are not yet registered under U.S. securities laws, are expected to be sold by July 17, 2024, with conditions. Additionally, LENZ Therapeutics plans to file for a resale registration of these shares with the SEC within 60 days post-closing, ensuring compliance and resale ability for the investor. The announcement was made public via a press release on July 15, 2024.
For a thorough assessment of LENZ stock, go to TipRanks’ Stock Analysis page.
